AnatomyDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Clinical Trials as TopicClinical Trials, Phase III as TopicResearch DesignClinical Trials, Phase II as TopicClinical Trials, Phase I as TopicControlled Clinical Trials as TopicTreatment OutcomePlacebosTime FactorsClinical ProtocolsFollow-Up StudiesPatient SelectionEarly Termination of Clinical TrialsSingle-Blind MethodProspective StudiesMulticenter Studies as TopicClinical Trials Data Monitoring CommitteesDrug Administration ScheduleDrug Therapy, CombinationSample SizeQuality of LifeCost-Benefit AnalysisAntineoplastic Combined Chemotherapy ProtocolsPilot ProjectsOutcome Assessment (Health Care)NeoplasmsAntineoplastic AgentsCombined Modality TherapySurvival AnalysisPatient ComplianceAdministration, OralSeverity of Illness IndexRecurrenceAnkle InjuriesIntention to Treat AnalysisEvidence-Based MedicineRisk FactorsDietary SupplementsQuestionnairesDisease-Free SurvivalAntigens, BacterialRandom AllocationResearch SubjectsSurvival RateUnited StatesPain MeasurementCognitive TherapyTrial of LaborRisk AssessmentPlacebo EffectInfusions, IntravenousBreast NeoplasmsStrokePrognosisPatient Education as TopicDrug EvaluationMeta-Analysis as TopicData Interpretation, StatisticalPatient SatisfactionDisease ProgressionInformed ConsentDrug CombinationsKaplan-Meier EstimateReproducibility of ResultsAnalysis of VariancePatient ParticipationChemotherapy, AdjuvantTreatment FailurePatient DropoutsGreat BritainAcute DiseaseLung NeoplasmsBias (Epidemiology)PregnancyChronic DiseaseTherapeutic Human ExperimentationPublishingHIV InfectionsOdontoblastsCounselingPainExerciseMyocardial InfarctionAntibodies, Monoclonal, HumanizedBiomedical ResearchPaclitaxelInfant, NewbornCluster AnalysisSpondylitisAntibodies, MonoclonalNeoplasm StagingCisplatinDrugs, InvestigationalRisk Reduction BehaviorBiological MarkersPublication BiasProgram EvaluationPredictive Value of TestsPhytotherapyNetherlands